secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001274737-24-000030
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen appoints Scott Kahn to board; three directors resign, board size reduced to 7
--------------------------------------------------------------------------------

- Directors Brian Birk, Wendy Johnson, and Ebetual Pallares to resign effective June 10, 2024; no disagreements cited.
- Scott D. Kahn, Ph.D. appointed as Class I director effective June 10, 2024; serves on Compensation and Nominating Committees.
- Board size decreases from 9 to 7 members at the effective date.
- Dr. Kahn brings 30+ years life sciences experience, including former CIO at Illumina and Chief Information/Privacy Officer at LunaPBC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000030/0001274737-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000030/exdx-20240422.htm
  HTML page:      https://secwatch.observer/filing/0001274737-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer